## LRCX: Lam Research Corporation - XLK: Technology

### Executive Summary

STRENGTH thesis confirmed: MRS_20 at 7.0% in lower entry zone (4.0-10.0%), top quartile (85th pct) cross-sectional ranking. Short-term MRS_5 (2.3%) confirms momentum alignment. Strong momentum (+5.9% 5-day acceleration). Outperforming sector by 5.8%.

- **Horizon:** 5-20 days (swing)
- **Risk Profile:** Moderate - momentum continuation
- **Stop Type:** Fixed 2xATR ($155.65)
- **If Wrong:** Exit if MRS_20 drops below entry zone or breaks stop
- **Invalidation:** MRS_20 exits entry zone or MRS_5 turns negative

### News

- **Articles:** 10
- **Sentiment:** Bullish (Bullish: 4, Bearish: 0)

**1. Axa S.A. Raises Holdings in Lam Research Corporation $LRCX**
- Source: MarketBeat | 20251209T083033 | Somewhat-Bullish | Relevance: 99%
-  Axa S.A. increased its stake in Lam Research Corporation, a semiconductor company, by 26% in Q2, bringing their total to 793,787 shares valued at approximately $77.3 million. Despite positive earnings and revenue performance, insiders have been net sellers of the stock, while several other institutional investors also adjusted their positions. The company recently announced a quarterly dividend of $0.26 per share, and analysts currently hold a "Moderate Buy" consensus rating with a target price of $152.87.

**2. Lam Research Corporation $LRCX Holdings Increased by Jump Financial LLC**
- Source: MarketBeat | 20251210T120812 | Somewhat-Bullish | Relevance: 98%
-  Jump Financial LLC significantly increased its stake in Lam Research Corporation (NASDAQ:LRCX) by 104.6% in the second quarter, now owning 46,338 shares valued at $4.51 million. Other institutional investors also adjusted their positions in the semiconductor company. Lam Research reported strong Q3 earnings, beating analyst estimates, and announced a quarterly dividend of $0.26 per share.

**3. Glenview Trust co Has $9.50 Million Holdings in Lam Research Corporation $LRCX**
- Source: MarketBeat | 20251211T140834 | Somewhat-Bullish | Relevance: 98%
-  Glenview Trust Co. has increased its stake in Lam Research Corporation (LRCX) by 11.7%, now owning 97,567 shares valued at $9.50 million. Institutional investors collectively own 84.61% of the company, and analysts generally rate the stock as a "Moderate Buy" with an average target price of $152.87, despite recent insider selling totaling $14.9 million.

**4. Lam Research Corp. stock outperforms competitors on strong trading day**
- Source: MarketWatch | 20251209T163400 | Bullish | Relevance: 98%
- Shares of Lam Research Corp. (LRCX) rose 1.89% to $165.81 on Tuesday, outperforming the broader market which saw declines for both the S&P 500 Index and the Dow Jones Industrial Average. This marks the third consecutive day of gains for the stock.

**5. Investment Management Corp of Ontario Increases Stock Position in Lam Research Corporation $LRCX**
- Source: MarketBeat | 20251209T141418 | Somewhat-Bullish | Relevance: 98%
-  Investment Management Corp of Ontario significantly increased its stake in Lam Research Corporation by 90.3% in the second quarter, now owning 108,638 shares valued at $10.575 million. Other institutional investors also adjusted their positions in the semiconductor company. Insider activity and analyst ratings are also detailed, with analysts giving Lam Research an average rating of "Moderate Buy" and a consensus target price of $152.87.

### Analyst Activity

**Target Signal:** NEUTRAL (Raises: 3, Lowers: 0)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-12-02 | Morgan Stanley | $158 | $137 | +15% |
| 2025-11-25 | UBS | $175 | $165 | +6% |
| 2025-11-12 | Citigroup | $190 | $175 | +9% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-12-02 | Morgan Stanley | main | Equal-Weight |
| 2025-11-25 | UBS | main | Buy |
| 2025-11-12 | Citigroup | main | Buy |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_SELLING** |
| Buys | 11 ($0.00M) |
| Sells | 6 ($14.07M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 39.7% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 6 / 3 |

**Top Holders:**
- Vanguard Group Inc: 10.4% (+0.3%)
- Blackrock Inc.: 9.9% (+1.7%)
- JPMORGAN CHASE & CO: 4.8% (+47.4%)
- State Street Corpora: 4.8% (+0.4%)
- Geode Capital Manage: 2.7% (-0.5%)

### Key Risks

1. Heavy insider selling: $14M sold (6 transactions in 90 days).
2. Market regime shift could impact high-beta names disproportionately.
3. Sector rotation risk if leadership changes from current market theme.

### Catalysts

- Analyst target momentum: 3 raises (avg +10%) could attract flows.
- AI/machine learning initiatives could drive multiple expansion if executed.
- Momentum building: MRS_20 improving +5.9% over 5 days suggests accumulation.

### Fundamentals

PEG ratio 2.39 elevated, pricing in significant growth expectations. Quality metrics strong (ROE 62%, ROA 20%, margin 30%). Balance sheet: strong liquidity (2.2x), $1.6B free cash flow. Analyst sentiment positive (3 raises, avg +10%). Insider selling cluster ($14.1M in 90 days), potential headwind. Institutional flow bullish (6 buying vs 3 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $212.7B |
| Beta | 1.78 |
| 52W Range | $56.32 - $169.69 |
| Short Interest | 3.0% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 2.39 |
| Forward P/E | 30.2 |
| Current P/E | 34.9 |
| YoY Growth | 15.8% |
| EPS Direction | RISING |

### Technicals

MRS_20 strengthening from 1.1% to 7.0% (+5.9% in 5 days), confirming momentum buildup. Currently in lower STRENGTH zone (4.0-10.0%), cross-sectional ranking at 85th percentile. MRS_5 at 2.3% confirms short-term momentum alignment. AM_20 at 9.2% shows strong absolute momentum above own 20MA. Outperforming sector by 5.8pp, stock-specific strength. Full SMA alignment bullish (above 20/50/200 SMAs). MACD histogram positive (1.38), confirming momentum.

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_20 | 6.95% (CS: 86) | Strong |
| RSI_14 | 64.9 | Neutral |
| MACD Histogram | 1.38 | Bullish |
| vs SMA20 | 1.092x | Above |
| vs SMA50 | 1.109x | Above |
| vs SMA200 | 1.592x | Above |

### Decision

- **Verdict:** AVOID
- **Thesis:** STRENGTH

### Trade Setup

- **Entry:** $168.71
- **Stop Loss:** $155.65 (7.7% risk)
- **Target:** $188.30 (R:R method)
- **Risk/Reward:** 1.50:1
- **Target Reasoning:** STRENGTH thesis targets 1.5x risk/reward based on historical edge

### Position Sizing

- **Shares:** 105
- **Position Value:** $17,714.55
- **Portfolio %:** 17.71%
- **Risk Dollars:** $1,380.00
- **Risk Per Trade:** 1.38%
- **Modifiers:** L1 115% | L2 120% | Combined 1.38x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.15x |
| L2 Sector | TREND (Zone A) | 1.20x |

*NORMAL regime with moderate risk appetite ahead of Fed decision. VIX at low 8th percentile signals complacency, but decent breadth and positive yield curve support selective positioning. Focus on quality names with earnings visibility.*

### Earnings

**Next:** 2026-01-28 (Est: $1.16)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $1.22 | $1.26 | +3.3% |
| 2025Q2 | $1.21 | $1.33 | +10.4% |
| 2025Q1 | $1.00 | $1.04 | +4.1% |
| 2024Q4 | $0.88 | $0.91 | +3.5% |

---
*RULE-based L3 | 2026-01-06 16:37 | MRS_20*